NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

This was always a distraction. Everything depends on relentless execution and getting investors excited about the future. They haven’t been able to do that in the last decade or so. Playing a victim card and excuses is never a winning strategy! Even today, the focus is on the lawsuit and not what’s coming post approval in terms of how they can accelerate regulatory approvals and reimbursements in other jurisdictions (particularly US, which is almost 20X of UK, and over 50% of the SAM), clinical trials, etc. They have no money and haven’t been able to convince big pharma to inject cash in NWBO, 4.5 years since data lock. Thats the sad reality!

Again, it will all boil down to significant cash injection from big pharma. Outside that, the stock will continue to lose value except a brief spike at the UK approval, which won’t sustain for long. Dilution will accelerate over the next couple of years and shorts will take advantage given the lethargic management crew and the cash situation.

One can also follow Phunware case. The stock is down from the date of ruling.